Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells - PubMed (original) (raw)
. 1989 Jan-Feb;7(1):41-54.
doi: 10.1007/BF02057180.
Affiliations
- PMID: 2783240
- DOI: 10.1007/BF02057180
Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells
A Sacchi et al. Clin Exp Metastasis. 1989 Jan-Feb.
Abstract
Proliferation capacity and MHC class I antigen expression of two Lewis lung carcinoma (3LL) metastatic variants (C87, BC215) grown under defined experimental conditions (serum-free defined medium or 10 per cent serum) have been studied following exposure to MoAb 135-13C which recognizes on these cells a tumor surface protein of 180,000 daltons (TSP-180). The results of this study indicate that the high metastatic clone (C87) binds higher amounts of MoAb to TSP-180 and Db antigens than does the low metastatic one (BC215), while both clones express very low amounts of Kb antigens. 3LL clones grown in 10 per cent serum or adapted in serum-free, defined medium show the same metastatic phenotype and MHC class I antigen expression, but when grown in defined medium exhibit increased capacity to bind MoAb 135-13C. However, the relative binding rate of 3LL clones grown in 10 per cent serum or in defined medium is unchanged: the high metastatic clone always showing higher capacity to bind MoAb to TSP-180. Furthermore, comparison of EGF binding sites on the cell surface of 3LL clones, grown in different culture conditions, demonstrates that the C87 clone binds higher amounts of labelled EGF and that this amount increases in serum-free defined medium, exactly as reported for TSP-180. In addition, competition experiments demonstrated that MoAb 135-13C does not compete for EGF binding sites on 3LL cell surface. Studies on cell proliferation following exposure to MoAb 135-13C, revealed that the low metastatic clone (BC215) is more actively stimulated than the high metastatic one. Moreover, similar data were obtained after exposure of 3LL clones to physiological amounts of different growth factors (i.e. EGF, MSA, insulin). Analysis of MHC class I antigen expression following exposure to MoAb 135-13C indicated that MoAb 135-13C induces on the cell surface of the C87 clone a transient low modulation of Db antigens. These results suggest that 3LL cells endowed with lower metastatic potential are more dependent on the microenvironmental conditions than the high metastasizing ones, and that MoAb 135-13C binding to 3LL cell surface stimulates proliferation as reported for several known growth factors.
Similar articles
- MHC antigens expressed on 3LL metastatic variants: correlation with the expression of a TSP-180 protein.
Sacchi A, Falcioni R, Tibursi G, Apollonj Ghetti C. Sacchi A, et al. Adv Exp Med Biol. 1988;233:141-50. doi: 10.1007/978-1-4899-5037-6_16. Adv Exp Med Biol. 1988. PMID: 3223380 - Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R, Kennel SJ, Giacomini P, Zupi G, Sacchi A. Falcioni R, et al. Cancer Res. 1986 Nov;46(11):5772-8. Cancer Res. 1986. PMID: 3756921 - Ligand-induced phosphorylation of a murine tumor surface protein (TSP-180) associated with metastatic phenotype.
Sacchi A, Falcioni R, Piaggio G, Gianfelice MA, Perrotti N, Kennel SJ. Sacchi A, et al. Cancer Res. 1989 May 15;49(10):2615-20. Cancer Res. 1989. PMID: 2713845 - Metastatic dissemination of 3LL variants after treatment with monoclonal antibody to a tumor-associated antigen.
Sacchi A, Kennel S Jr, Natali PG, Tibursi G, Ghetti CA. Sacchi A, et al. Clin Exp Metastasis. 1987 Sep;5(3):245-57. doi: 10.1007/BF00124306. Clin Exp Metastasis. 1987. PMID: 3652554 - Metastatic phenotype: growth factor dependence and integrin expression.
Perrotti D, Cimino L, Falcioni R, Tibursi G, Gentileschi MP, Sacchi A. Perrotti D, et al. Anticancer Res. 1990 Nov-Dec;10(6):1587-97. Anticancer Res. 1990. PMID: 2285230
Cited by
- Retinoic acid negatively regulates beta 4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma cell line.
Gaetano C, Melchiori A, Albini A, Benelli R, Falcioni R, Modesti A, Modica A, Scarpa S, Sacchi A. Gaetano C, et al. Clin Exp Metastasis. 1994 Jan;12(1):63-72. doi: 10.1007/BF01784335. Clin Exp Metastasis. 1994. PMID: 8287622 - Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes.
Adams JC, Watt FM. Adams JC, et al. J Cell Biol. 1991 Nov;115(3):829-41. doi: 10.1083/jcb.115.3.829. J Cell Biol. 1991. PMID: 1918165 Free PMC article. - Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes.
Stepp MA, Spurr-Michaud S, Tisdale A, Elwell J, Gipson IK. Stepp MA, et al. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8970-4. doi: 10.1073/pnas.87.22.8970. Proc Natl Acad Sci U S A. 1990. PMID: 2247472 Free PMC article.
References
- Cancer Res. 1980 Jul;40(7):2153-9 - PubMed
- Cancer Res. 1979 Aug;39(8):2934-9 - PubMed
- Cancer Res. 1986 Feb;46(2):707-12 - PubMed
- Immunobiology. 1980 Jul;157(2):89-98 - PubMed
- Proc Natl Acad Sci U S A. 1986 Aug;83(16):6007-11 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous